GMO Registry: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GMO Registry
Largest movements
- Cash +€80,498
up €80,498 (+65.7%), from €122,601 to €203,099
mainly Other debts (+€45,635) and Receivables within one year (+€24,213)
- Receivables within one year -€24,213
down €24,213 (-33.8%), from €71,708 to €47,495
of which Other amounts receivable: -€14,144
- Other debts +€45,635
up €45,635 (+18.2%), from €251,194 to €296,829
- Profit (loss) carried forward +€14,407
up €14,407 (+11.9%), from -€120,810 to -€106,403
- Gross operating margin +€67,621
up €67,621 (+114%), from €59,069 to €126,690
- Staff costs +€40,016
up €40,016 (+57.1%), from €70,133 to €110,150
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €194,309 | €251,926 | +€57,616 | +29.7% |
| Current assets | 29/58 | €194,309 | €251,926 | +€57,616 | +29.7% |
| Amounts receivable within one year | 40/41 | €71,708 | €47,495 | -€24,213 | -33.8% |
| Trade receivables | 40 | €56,010 | €45,941 | -€10,069 | -18.0% |
| Other amounts receivable | 41 | €15,699 | €1,554 | -€14,144 | -90.1% |
| Cash at bank and in hand | 54/58 | €122,601 | €203,099 | +€80,498 | +65.7% |
| Deferred charges and accrued income | 490/1 | - | €1,332 | +€1,332 | |
| Total equity and liabilities | 10/49 | €194,309 | €251,926 | +€57,616 | +29.7% |
| Equity | 10/15 | -€59,310 | -€44,903 | +€14,407 | +24.3% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€120,810 | -€106,403 | +€14,407 | +11.9% |
| Amounts payable | 17/49 | €253,619 | €296,829 | +€43,210 | +17.0% |
| Amounts payable within one year | 42/48 | €253,619 | €296,829 | +€43,210 | +17.0% |
| Trade debts | 44 | €272 | - | -€272 | |
| Suppliers | 440/4 | €272 | - | -€272 | |
| Taxes, remuneration and social security | 45 | €2,153 | - | -€2,153 | |
| Taxes | 450/3 | €2,153 | - | -€2,153 | |
| Other amounts payable | 47/48 | €251,194 | €296,829 | +€45,635 | +18.2% |
| Remuneration, social security and pensions | 62 | €70,133 | €110,150 | +€40,016 | +57.1% |
| Other operating charges | 640/8 | €434 | - | -€434 | |
| Gross operating margin | 9900 | €59,069 | €126,690 | +€67,621 | +114% |
| Operating profit (loss) | 9901 | -€11,498 | €16,540 | +€28,039 | |
| Financial income | 75/76B | - | €52 | +€52 | |
| Recurring financial income | 75 | - | €52 | +€52 | |
| Financial charges | 65/66B | €2,879 | €2,185 | -€693 | -24.1% |
| Recurring financial charges | 65 | €2,879 | €2,185 | -€693 | -24.1% |
| Profit (loss) for the period before taxes | 9903 | -€14,377 | €14,407 | +€28,784 | |
| Profit (loss) for the period | 9904 | -€14,377 | €14,407 | +€28,784 | |
| Profit (loss) for the period to be appropriated | 9905 | -€14,377 | €14,407 | +€28,784 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.